Antares Pharma, Inc. (ATRS)

Operating Cash Flow Growth

67.96%

TTM · Period ending:

ATRS logo

ATRS Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported67.96%
ATRS TTM Cash from Operations YoY % (-12.47% → 67.96%)
High-resolution chart · PNG

ATRS operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Antares Pharma, Inc. Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
67.9648%
71.7589%
161.5573%
108.2825%
154.752%
300.8479%
178.6148%
153.3493%
129.8716%
38.7195%
6.3288%
20.1874%
7.3916%
24.9935%
6.3708%
-38.9931%
-65.2647%
-51.9848%
-35.149%
2.4247%
29.2574%
46.115%
55.7044%
48.5172%
28.3918%
-7.0843%
-43.1323%
-70.3374%
-67.9013%
-75.9289%
-40.2883%
-48.4915%
-37.583%
-42.9215%
-183.7093%
-162.9141%
-649.3888%
-443.7669%
-9.3262%
6.4905%
67.8955%
68.319%
31.3011%
-27.5768%
-3.3245%
-19.2136%
-42.2847%
57.9973%
49.3064%
50.6068%
45.3381%
-21.2594%
-33.097%
-91.3957%
-112.0591%
-92.3895%
-149.0888%
11.8301%
31.7986%
36.3932%
58.4438%
15.2452%
20.1756%
23.8834%
10.0224%
-0.7146%
-54.8186%
-68.234%
-72.2809%
-101.7074%
-24.2063%
-41.0037%
-26.0136%
36.0196%
-204.7218%
-180.6531%
-72.0271%
-109.2224%
79.7955%
79.908%
60.0292%
28.8748%
-105.4533%
-89.1331%
-82.9225%
-41.7178%
15.4273%
19.4831%
36.6644%
47.4551%
-4.9772%
-26.0169%
-76.7989%
-60.5513%
-7.8863%
-12.4694%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.